Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity and behavior after early life seizures
探索性测定 L 型钙通道在介导早期癫痫发作后异常可塑性和行为中的作用
基本信息
- 批准号:9454781
- 负责人:
- 金额:$ 18.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:ARHGEF5 geneAddressAgeAnatomyBehaviorBehavioralBindingBiochemistryBiological MarkersCattleCellsChildhoodChronicClinicalClinical ResearchDataDevelopmentEarly treatmentEpilepsyFMRPFRAP1 geneFunctional disorderFutureGeneticGenetic ModelsHippocampus (Brain)Hyperactive behaviorImmunohistochemistryIn VitroInjuryIntellectual functioning disabilityIsradipineL-Type Calcium ChannelsLifeLinkLong-Term DepressionLong-Term PotentiationMeasurementMeasuresMediatingModelingNeurocognitionNeurocognitiveNeurocognitive DeficitPathway interactionsPatientsPeptidesPeritoneumPharmacologyPlayProtein phosphataseProteinsPublishingRattusRodent ModelRoleSeizuresSignal TransductionSliceSynaptic plasticitySyndromeTestingWorkautism spectrum disorderbasebehavioral studyepileptic encephalopathiesexperimental studyimmunocytochemistryimprovedkainatenovelnovel therapeuticsprotein protein interactionsecondary outcometherapeutic target
项目摘要
ABSTRACT: “Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity
and behavior after early life seizures”
Pediatric epileptic encephalopathy (P-EE) syndromes, characterized by frequent early-life seizures (ELS),
are associated with catastrophic neurocognitive impairment including autism spectrum disorder and intellectual
disability (ASD/ID). P-EE can be associated with injury or genetic causes. Currently, clinical opinions by leaders
vary widely in the field, with some believing that ELS adds insult to injury and favoring the aggressive treatment
of ELS. For most of our patients, “the cow is already out of the barn”: ELS has already happened and there are
no therapies to address the long-term consequences of ELS itself. Therefore, there is an urgent need to
investigate these issues with rodent models: 1) What are the mechanisms? 2) Can this be treated?
We hypothesize that hyperactive L-type calcium channels (LTCCs) play a substantial role to mediate
abnormal plasticity and behavior in P-EE. Studies in CA1 hippocampal slices in vitro will pharmacologically
compare mechanistic changes in synaptic plasticity (SA1) mediated by LTCCs that have developed chronically
(P60+) after ELS. Behavioral studies (SA2) will determine the neurocognitive benefit of an LTCC antagonist after
ELS. Our rationale is that these studies will segue to mechanistically inspired, novel therapeutics for
neurocognitive deficits associated with ELS where none exist that could provide significant societal benefit.
Specific Aim 1 (SA1): Mechanistically link KA-ELS-mediated LTCC dysfunction to disruption of key LTCC
protein-protein interactions that impact mGluR-LTD.
Specific Aim 2 (SA2): Determine whether chronic LTCC antagonism ameliorates neurocognitive impairment
after KA-ELS.
These exploratory studies will lay the groundwork to segue into comprehensive studies investigating the
mechanistic roles of LTCC in mediating neurocognitive deficits in P-EE with ELS. By understanding
mechanistically how LTCC modulate plasticity after ELS (SA1) and determining whether broad-spectrum LTCC
inhibition improves neurocognition (SA2), we can then advance LTCC-related neurotherapeutic strategies for
application to genetic models of P-EE with ELS, to be characterized in future studies. These studies are
essential, as genetic or other protein replacement strategies in P-EE may be insufficient to correct the long-term
consequences of ELS.
摘要:“探索性确定L型钙通道在介导异常可塑性中的作用
和早期癫痫发作后的行为”
小儿癫痫性脑病(P-EE)综合征,以频繁的早期癫痫发作(ELS)为特征,
与灾难性的神经认知障碍有关,包括自闭症谱系障碍和智力障碍。
自闭症(ASD/ID)。P-EE可能与损伤或遗传原因有关。目前,领导临床意见
在该领域的差异很大,有些人认为ELS增加了伤害的侮辱,并赞成积极的治疗
的ELS。对于我们的大多数患者来说,“牛已经出了谷仓”:ELS已经发生,
没有治疗方法来解决ELS本身的长期后果。因此,迫切需要
用啮齿动物模型研究这些问题:1)机制是什么?2)这可以治疗吗?
我们推测,过度活跃的L型钙通道(LTCCs)在介导细胞凋亡中起重要作用。
在体外对CA 1海马脑片的研究将证实P-EE的可塑性和行为异常。
比较慢性发展的LTCC介导的突触可塑性(SA 1)的机制变化
(P60+)ELS之后。行为研究(SA 2)将确定LTCC拮抗剂的神经认知益处,
ELS。我们的理由是,这些研究将继续机制启发,新的治疗方法,
与ELS相关的神经认知缺陷,其中不存在可以提供显著社会效益的缺陷。
具体目标1(SA 1):将KA-ELS介导的LTCC功能障碍与关键LTCC的破坏机制联系起来
影响mGluR-LTD的蛋白质间相互作用。
具体目标2(SA 2):确定慢性LTCC拮抗剂是否改善神经认知障碍
在KA-ELS之后。
这些探索性研究将为深入开展全面研究奠定基础,
LTCC在ELS介导P-EE神经认知缺陷中的机制作用。通过了解
LTCC如何在ELS(SA 1)后机制性地调节可塑性,并确定广谱LTCC是否
抑制改善神经认知(SA 2),我们可以推进LTCC相关的神经治疗策略,
P-EE与ELS的遗传模型的应用,在未来的研究中进行表征。这些研究
这是必要的,因为P-EE中的遗传或其他蛋白质替代策略可能不足以纠正长期
的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY A BENKE其他文献
TIMOTHY A BENKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY A BENKE', 18)}}的其他基金
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
科罗拉多大学落基山 NeuroNEXT (UNCOMON) 临床研究联盟。
- 批准号:
10744629 - 财政年份:2023
- 资助金额:
$ 18.99万 - 项目类别:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
CDKL5 缺乏症临床试验准备的生物标志物和核心临床结果指标的多中心验证
- 批准号:
10569019 - 财政年份:2021
- 资助金额:
$ 18.99万 - 项目类别:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
CDKL5 缺乏症临床试验准备的生物标志物和核心临床结果指标的多中心验证
- 批准号:
10338135 - 财政年份:2021
- 资助金额:
$ 18.99万 - 项目类别:
Colorado Neurological Sciences Academic Development Award (NSADA)
科罗拉多神经科学学术发展奖 (NSADA)
- 批准号:
8788338 - 财政年份:2015
- 资助金额:
$ 18.99万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8217756 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8533043 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8323875 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8909216 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)
落基山神经科学临床研究网络 (RMNNCS)
- 批准号:
8866484 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8722047 - 财政年份:2011
- 资助金额:
$ 18.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.99万 - 项目类别:
Research Grant














{{item.name}}会员




